Tirzepatide (Mounjaro) for weight management - Updated 24.02.26
On 23rd June 2025, it was announced that people living with obesity will be able to begin accessing tirzepatide (Mounjaro®) for weight loss purposes in primary care (GP) settings. However, the national roll out does not mean all people will be able to get a prescription for tirzepatide (Mounjaro®).
In mid and south Essex, tirzepatide (Mounjaro®) will be available through Tier 3 specialist weight management services to individuals facing the most significant health risks related to their weight.
Click here to read the eligibility criteria for the Tier 3 weight management service. Please note that acceptance onto the Tier 3 programme does not guarantee access to weight loss medications. Medication is offered via this service where available and appropriate for patient’s clinical needs.
Tirzepatide (Mounjaro®) will not be accessible to everyone who wishes to use it. People with the highest health risks and who meet the clinical criteria will be prioritised. Full qualifying clinical criteria is a BMI (Body Mass Index) of 40 or more plus four or more of the following diagnosed health conditions:
- type 2 diabetes
- high blood pressure
- heart disease
- obstructive sleep apnoea
- abnormal blood fats (dyslipidaemia)
Access to the drug must be accompanied by wraparound care which will include support for people to make dietary changes and to increase physical activity. Tirzepatide will not be prescribed as a standalone treatment, and patients must fully participate with the wraparound support programme.
Tirzepatide (Mounjaro ®) might not be considered clinically suitable for everyone, and not everyone who meets the eligibility criteria will want to use it to support their weight loss. Therefore, there are a number of alternative weight management services available in mid and south Essex.
If you are currently paying for Mounjaro privately and would like to access it through the NHS, please be aware that you must meet the local NHS eligibility criteria at the time you are referred to the Tier 3 weight management service.
If you are currently paying for Mounjaro privately for weight loss and now wish to stop or taper off the drug, please speak with your private provider.